Cardiovascular Disease: New Care Strategies for Type 1 Diabetes

We are testing a new care approach to reduce cardiovascular disease risk in people with type 1 diabetes. This study also evaluates the safety of a medication called finerenone in this high-risk group.

>2 years Confirmation phase (III)No Placebo Partially Remote Investigational Medicines Oral InjectionCardiologyEndocrinologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Ozempic

Ozempic is a medicine that helps lower blood sugar in adults with type 2 diabetes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Finerenone

Finerenone is a substance that helps protect the kidneys and heart in adults with chronic kidney disease related to type 2 diabetes.

Semaglutide

Semaglutide is a substance that helps lower blood sugar in people with type 2 diabetes and can also reduce appetite to aid weight loss.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Sotagliflozin

Bay 94-8862

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Rybelsus

Wegovy

Wegovy Flextouch

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Steno Diabetes Center Nordjylland

Steno Diabetes Center Nord

Aalborg, Denmark

Steno Diabetes Center Aarhus

Århus, Denmark

Rigshospitalet

Endokrinologisk afd.

Copenhagen, Denmark

Sponsor: Steno Diabetes Center Copenhagen

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.